Sale!

Replica: Osimertinib EGFRm NSCLC Treatment

Original price was: $688.00.Current price is: $529.00.

Targeted therapy for EGFR-mutated NSCLC, third-generation irreversible EGFR-TKI, active against CNS metastasis, for Ex19Del or L858R mutations, third-line treatment.,

SKU: SKU67EM9FULM Category:
Guaranteed Safe Checkout

Targeted therapy for EGFR-mutated NSCLC, third-generation irreversible EGFR-TKI, active against CNS metastasis, for Ex19Del or L858R mutations, third-line treatment.,

Scroll to Top